Huaigeng Xu, M.D.,Ph.D. (he/him/his)

University of California, San Francisco (UCSF), United States

Stem Cell Reports Author
Dr. Huaigeng Xu is a Postdoctoral Fellow at the University of California, San Francisco (UCSF), working in the lab of Dr. Robert Blelloch. His research focuses on the differentiation of human iPSCs into immune cell lineages, particularly dendritic cells, for applications in cancer immunotherapy. He is interested in developing universal cell-based therapies using gene editing and stem cell technologies. Dr. Xu has a multidisciplinary background in stem cell biology, immunology, and regenerative medicine.

Presentation(s):

• AI AND CANCER EVOLUTION

  Friday, June 13, 2025
  8:30 AM – 10:00 AM HK Time

• ENGINEERED UNIVERSAL IPSC-DERIVED DENDRITIC CELLS DRESSED WITH TUMOR-MHC-PEPTIDE COMPLEXES AS A CANCER VACCINE

  Friday, June 13, 2025
  8:55 AM – 9:05 AM HK Time